Related references
Note: Only part of the references are listed.Ubiquitin Ligases and Cell Cycle Control
Leonardo K. Teixeira et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
What underlies the diversity of brain tumors?
Fredrik J. Swartling et al.
CANCER AND METASTASIS REVIEWS (2013)
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
Markus Brockmann et al.
CANCER CELL (2013)
Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression
Linsey Reavie et al.
CANCER CELL (2013)
Notch1-Induced Brain Tumor Models the Sonic Hedgehog Subgroup of Human Medulloblastoma
Sivaraman Natarajan et al.
CANCER RESEARCH (2013)
Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
Chia-Hsin Chan et al.
CELL (2013)
CDK-mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer
Diana Cepeda et al.
EMBO MOLECULAR MEDICINE (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
FBXL2-and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade
Shafi Kuchay et al.
NATURE CELL BIOLOGY (2013)
HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling
Z. Hartman et al.
ONCOGENE (2013)
TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth
K. Di et al.
ONCOGENE (2013)
Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Lynn Bjerke et al.
CANCER DISCOVERY (2013)
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2012)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Fredrik J. Swartling et al.
CANCER CELL (2012)
A Mouse Model of the Most Aggressive Subgroup of Human Medulloblastoma
Daisuke Kawauchi et al.
CANCER CELL (2012)
Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc
Hong Sug Kim et al.
CANCER RESEARCH (2012)
Malignant Glioma: Lessons from Genomics, Mouse Models, and Stem Cells
Jian Chen et al.
CELL (2012)
Regulation of Pluripotency and Cellular Reprogramming by the Ubiquitin-Proteasome System
Shannon M. Buckley et al.
CELL STEM CELL (2012)
Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
Lily Wu et al.
CHEMISTRY & BIOLOGY (2012)
Pirh2 RING-finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy
Yong-Sam Jung et al.
FEBS LETTERS (2012)
Mdm2 and MdmX partner to regulate p53
Xinjiang Wang et al.
FEBS LETTERS (2012)
HECT and RING finger families of E3 ubiquitin ligases at a glance
Meredith B. Metzger et al.
JOURNAL OF CELL SCIENCE (2012)
Cellular functions of the DUBs
Michael J. Clague et al.
JOURNAL OF CELL SCIENCE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
Luca Busino et al.
NATURE CELL BIOLOGY (2012)
USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
Pieter J. A. Eichhorn et al.
NATURE MEDICINE (2012)
TGFβ signalling in context
Joan Massague
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
Bret B. Friday et al.
NEURO-ONCOLOGY (2012)
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
Annette Kuenkele et al.
NEURO-ONCOLOGY (2012)
Preliminary experience with personalized and targeted therapy for pediatric brain tumors
Johannes E. Wolff et al.
PEDIATRIC BLOOD & CANCER (2012)
Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
Linda J. Valentijn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Key role for ubiquitin protein modification in TGFβ signal transduction
Miriam De Boeck et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
Myc proteins in brain tumor development and maintenance
Fredrik J. Swartling
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
The ubiquitin-proteasome system in glioma cell cycle control
Panagiotis J. Vlachostergios et al.
CELL DIVISION (2012)
Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway
Azadeh Arabi et al.
NATURE COMMUNICATIONS (2012)
E3 Ubiquitin Ligase Cbl-b Regulates Pten via Nedd4 in T Cells Independently of Its Ubiquitin Ligase Activity
Hui Guo et al.
CELL REPORTS (2012)
SCFFbw7 Modulates the NFκB Signaling Pathway by Targeting NFκB2 for Ubiquitination and Destruction
Hidefumi Fukushima et al.
CELL REPORTS (2012)
Targeting the mTOR-DEPTOR Pathway by CRL E3 Ubiquitin Ligases: Therapeutic Application
Yongchao Zhao et al.
NEOPLASIA (2012)
Medulloblastomics: the end of the beginning
Paul A. Northcott et al.
NATURE REVIEWS CANCER (2012)
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2011)
The two faces of FBW7 in cancer drug resistance
Zhiwei Wang et al.
BIOESSAYS (2011)
Deubiquitinases in the regulation of NF-kappa B signaling
Edward W. Harhaj et al.
CELL RESEARCH (2011)
The F-box protein Fbw7 is required for cerebellar development
Anett Jandke et al.
DEVELOPMENTAL BIOLOGY (2011)
Validation of MdmX as a therapeutic target for reactivating p53 in tumors
Daniel Garcia et al.
GENES & DEVELOPMENT (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bortezomib stabilizes NOXA and triggers ROS-associated apoptosis in medulloblastoma
Sachiko Ohshima-Hosoyama et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
GLI2 Is a Potential Therapeutic Target in Pediatric Medulloblastoma
Pawel Buczkowicz et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
Amy M. Ruschak et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Hiroyuki Inuzuka et al.
NATURE (2011)
WWP2 is an E3 ubiquitin ligase for PTEN
Subbareddy Maddika et al.
NATURE CELL BIOLOGY (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53
Hong Wu et al.
NATURE MEDICINE (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
NFKBIA Deletion in Glioblastomas.
Markus Bredel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The von Hippel-Lindau Tumor Suppressor Protein Promotes c-Cbl-Independent Poly-Ubiquitylation and Degradation of the Activated EGFR
Liang Zhou et al.
PLOS ONE (2011)
Novel functions for the anaphase-promoting complex in neurobiology
Sidharth V. Puram et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia
Ronan T. Swords et al.
BLOOD (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?
Philip Cohen et al.
CELL (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
APC/CCdc20 targets E2F1 for degradation in prometaphase
Melissa J. Peart et al.
CELL CYCLE (2010)
Suppressor of fused and Spop regulate the stability, processing and function of Gli2 and Gli3 full-length activators but not their repressors
Chengbing Wang et al.
DEVELOPMENT (2010)
The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy
Lars-Gunnar Larsson et al.
EXPERIMENTAL CELL RESEARCH (2010)
Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells
Seung H. Choi et al.
GENES & DEVELOPMENT (2010)
Pleiotropic role for MYCN in medulloblastoma
Fredrik J. Swartling et al.
GENES & DEVELOPMENT (2010)
Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers
Maher S. Saifo et al.
MOLECULAR CANCER (2010)
Subtypes of medulloblastoma have distinct developmental origins
Paul Gibson et al.
NATURE (2010)
Ubiquitylation of the amino terminus of Myc by SCFβ-TrCP antagonizes SCFFbw7-mediated turnover
Nikita Popov et al.
NATURE CELL BIOLOGY (2010)
Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies
Selvaraju Veeriah et al.
NATURE GENETICS (2010)
Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun
Joerg D. Hoeck et al.
NATURE NEUROSCIENCE (2010)
The role of primary cilia in neuronal function
Jeong Ho Lee et al.
NEUROBIOLOGY OF DISEASE (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Jason T. Huse et al.
NATURE REVIEWS CANCER (2010)
Malignant Gliomas with Primitive Neuroectodermal Tumor-like Components: A Clinicopathologic and Genetic Study of 53 Cases
Arie Perry et al.
BRAIN PATHOLOGY (2009)
Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
Tobias Otto et al.
CANCER CELL (2009)
PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
Jeremy M. R. Lambert et al.
CANCER CELL (2009)
Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation
Ping Xu et al.
CELL (2009)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition
Carl-Henrik Heldin et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
GFAP Promoter Driven Transgenic Expression of PDGFB in the Mouse Brain Leads to Glioblastoma in a Trp53 null Background
Sanna-Maria Hede et al.
GLIA (2009)
From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000)
P. Frange et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Two Tumor Suppressors, p27Kip1 and Patched-1, Collaborate to Prevent Medulloblastoma
Olivier Ayrault et al.
MOLECULAR CANCER RESEARCH (2009)
Nonproteolytic Functions of Ubiquitin in Cell Signaling
Zhijian J. Chen et al.
MOLECULAR CELL (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression
W. D. Thomas et al.
ONCOGENE (2009)
A novel small-molecule inhibitor of NF-κB signaling
Hiroto Nakajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Targeting the p27 E3 ligase SCFSkp2 results in p27-and Skp2-mediated cell-cycle arrest and activation of autophagy
Qing Chen et al.
BLOOD (2008)
The Fbxw7/hCdc4 tumor suppressor in human cancer
YingMeei Tan et al.
CANCER LETTERS (2008)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
Modelling Myc inhibition as a cancer therapy
Laura Soucek et al.
NATURE (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein
Xudong Zhao et al.
NATURE CELL BIOLOGY (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle's Dynamics and Signaling
Wei Li et al.
PLOS ONE (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization
Fatemeh Fouladkou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression
Jian-Hua Mao et al.
SCIENCE (2008)
Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo
J. I. Johnsen et al.
ONCOGENE (2008)
WNT signaling pathway and stem cell signaling network
Masuko Katoh et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Matthias Lauth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Genetic pathways to primary and secondary glioblastoma
Hiroko Ohgaki et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN
Xinjiang Wang et al.
CELL (2007)
Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch- dependent ubiquitination
Lucia Di Marcotullio et al.
NATURE CELL BIOLOGY (2006)
Introduction to NF-κB:: players, pathways, perspectives
T. D. Gilmore
ONCOGENE (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2006)
Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth
Anna Lasorella et al.
NATURE (2006)
Origin of oligodendrocytes in the subventricular zone of the adult brain
Benedicte Menn et al.
JOURNAL OF NEUROSCIENCE (2006)
PDGFRα-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling
Erica L. Jackson et al.
NEURON (2006)
Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells
Norman L. Lehman et al.
CELL CYCLE (2006)
Gli2 is targeted for ubiquitination and degradation by β-TrCP ubiquitin ligase
Neehar Bhatia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
S. Farzana Hussain et al.
NEURO-ONCOLOGY (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Gene expression analyses reveal molecular relationships among 20 regions of the human CNS
RB Roth et al.
NEUROGENETICS (2006)
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma
Qi-Wen Fan et al.
CANCER CELL (2006)
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
LX Sun et al.
CANCER CELL (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Notch signalling in vertebrate neural development
A Louvi et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Evidence for the direct involvement of βTrCP in Gli3 protein processing
BW Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Notch signalling: a simple pathway becomes complex
Sarah J. Bray
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The ubiquitin ligase HectH9 regulates transcriptional activation by myc and is essential for tumor cell proliferation
S Adhikary et al.
CELL (2005)
Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas
M Bredel et al.
CANCER RESEARCH (2005)
Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation
J Seoane et al.
CELL (2004)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases
MD Marmor et al.
ONCOGENE (2004)
Oncogenic aberrations of cullin-dependent ubiquitin ligases
D Guardavaccaro et al.
ONCOGENE (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
HM Wang et al.
LABORATORY INVESTIGATION (2004)
Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis
AH Shih et al.
CANCER RESEARCH (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
Mastermind recruits CycC:CDK8 to phosphorylate the notch ICD and coordinate activation with turnover
CJ Fryer et al.
MOLECULAR CELL (2004)
Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors
AM Kenney et al.
DEVELOPMENT (2004)
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation
M Welcker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Notch1 and Notch2 have opposite effects on embryonal brain tumor growth
X Fan et al.
CANCER RESEARCH (2004)
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7
M Yada et al.
EMBO JOURNAL (2004)
Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation
Y Mosesson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Escape from Cbl-mediated downregulation: A recurrent theme for oncogenic deregulation of receptor tyrosine kinases
P Peschard et al.
CANCER CELL (2003)
Prophase destruction of Emi1 by the SCFβTrCP/Slimb ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase
F Margottin-Goguet et al.
DEVELOPMENTAL CELL (2003)
Control of meiotic and mitotic progression by the F box protein β-Trcp1 in vivo
D Guardavaccaro et al.
DEVELOPMENTAL CELL (2003)
Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization
MHH Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The F-Box protein Skp2 participates in c-Myc protelosornal degradation and acts as a cofactor for c-Myc-regulated transcription
N von der Lehr et al.
MOLECULAR CELL (2003)
Skp2 regulates Myc protein stability and activity
SY Kim et al.
MOLECULAR CELL (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo
K Lai et al.
NATURE NEUROSCIENCE (2003)
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation
PS Knoepfler et al.
GENES & DEVELOPMENT (2002)
Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot
D Schiffer et al.
NEUROSCIENCE LETTERS (2002)
E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1
JY Hsu et al.
NATURE CELL BIOLOGY (2002)
The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian sel-10 homolog
C Öberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor
N Gupta-Rossi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins
M Yokouchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells
DY Fang et al.
NATURE IMMUNOLOGY (2001)
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
C Dai et al.
GENES & DEVELOPMENT (2001)
Themes and variations on ubiquitylation
AM Weissman
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells
D Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
Ubiquitin-mediated degradation of the proapoptotic active form of bid - A functional consequence on apoptosis induction
K Breitschopf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
SY Fang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
MdmX protects p53 from Mdm2-mediated degradation
MW Jackson et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
APC mutations in sporadic medulloblastomas
HT Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
